This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Mind of Wilhelmus HIM Drinkenburg
Introduction
Wilhelmus HIM Drinkenburg is an esteemed inventor based in Molenschot, Netherlands. He has made notable contributions to the field of medical innovations, particularly in treating sleep-wake disorders. With a single patent to his name, Drinkenburg's work exemplifies the intersection of creativity and scientific advancement.
Latest Patents
Drinkenburg holds a patent for a method of treating Excessive Daytime Sleepiness (EDS) in individuals. This innovative treatment involves administering a therapeutically effective amount of a specific compound, which includes a complex formula designed to enhance its effectiveness. The details of the compound reflect a comprehensive approach to combating sleep disorders, showcasing Drinkenburg's dedication to improving patients' quality of life.
Career Highlights
Currently affiliated with Sk Biopharmaceuticals Co., Ltd., Drinkenburg has established himself as a key figure in the biopharmaceutical industry. His expertise in the formulation of innovative therapies for sleep disorders highlights his commitment to addressing real-world health challenges. His patent underscores his capacity to translate complex scientific ideas into practical applications.
Collaborations
Throughout his career, Drinkenburg has worked alongside accomplished professionals such as Abdallah Ahnaou and Joseph Palumbo. Their collaborations have likely enriched his research and development processes, fostering an environment of innovation and shared expertise in the field of biopharmaceuticals.
Conclusion
Wilhelmus HIM Drinkenburg is a remarkable inventor whose work reflects a profound understanding of medical science and innovation. His patented method for treating EDS not only showcases his inventive prowess but also underscores the importance of collaborative efforts in the advancement of healthcare solutions. As he continues to contribute to the field, his ongoing journey is one to watch in the realm of biopharmaceutical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile